Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Christine Duncan is a physician-researcher whose work focuses on the cellular therapy of children and young adults with rare inherited diseases. She is a Principal Investigator, Staff Physician, and Medical Director of Clinical Research and Clinical Development of the Gene Therapy Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Assistant Professor of Pediatrics at Harvard Medical School, and Associate Clinical Director of Inpatient Pediatric Hematopoietic Stem Cell Transplant Service at Boston Children's Hospital. In addition to her work on allogeneic and gene therapy for rare pediatric diseases, Dr Duncan investigates the long-term complications of cellular therapies.
Dr Karina Yazdanbakhsh is the Head of the Laboratory of Complement Biology of the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC). She received her PhD in molecular biology from the National Institute for Medical Research (MRC) at Mill Hill London and did her postdoctoral training in molecular and cellular immunology at Columbia and Rockefeller Universities. She joined NYBC in 1996 and served as the Executive Director of LFKRI from 2016–2019. She has extensive experience in transfusion immunology and her current research is on patient-orientated translational studies focusing on immune regulatory networks in thrombocytopenia and hemolytic anemia and understanding sickle cell immune-pathophysiology.
Dr Yazdanbakhsh has served on numerous National Institutes of Health (NIH) review panels and has been a member of several committees for the American Association of Blood Banks (AABB) and the American Society of Hematology. She was the Chair of the Abstract Selection Committee of AABB from 2016–2020 and the Chair of the Scientific Committee of ASH and currently serves on the Editorial Board of Transfusion. She has spoken as an invited speaker and chair at many national and international meetings, including AABB, American Society of Hematology Meeting, European Hematology Association, and International Society of Blood Transfusion. She was inducted into the Hall of Fame of the National Blood Foundation of AABB in 2016 for her contributions to transfusion medicine.